P1.01-109 Phase II Trial of Pemetrexed/Carboplatin/Bevacizumab +/- Atezolizumab in NSCLC Patients That Are EGFR Mutated or Never Smoked
- Resource Type
- Abstract
- Source
- In
Journal of Thoracic Oncology October 2019 14(10) Supplement:S404-S404 - Subject
- Language
- ISSN
- 1556-0864